[1]RSCAdvances,2015,vol.5,#60,p.48506-48515
[2]ACSCatalysis,2013,vol.3,#7,p.1420-1430
[3]Chemistry-AEuropeanJournal,2013,vol.19,#13,p.4156-4168
[1]LettersinOrganicChemistry,2010,vol.7,#4,p.314-318
Title: Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5.
Journal: Acta pharmacologica Sinica 20111201
Title: The effect of adjuvant dimethylenastron, a mitotic Kinesin Eg5 inhibitor, in experimental glaucoma filtration surgery.
Journal: Current eye research 20101201
Title: Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.
Journal: Journal of medicinal chemistry 20100812
Title: Biochemical analysis of cellular target of S-trityl-L-cysteine derivatives using affinity matrix.
Journal: Bioorganic & medicinal chemistry letters 20100301
Title: New chemical tools for investigating human mitotic kinesin Eg5.
Journal: Bioorganic & medicinal chemistry 20071001
Title: Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
Journal: Cancer chemotherapy and pharmacology 20070201
Title: The pKa value of the active site histidine in photo-oxidised papain.
Journal: FEBS letters 19760101
Title: Gartner M, et al. Development and biological evaluation of potent and specific inhibitors of mitotic Kinesin Eg5. Chembiochem. 2005 Jul;6(7):1173-7.
Title: Sun XD, et al. Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5. Acta Pharmacol Sin. 2011 Dec;32(12):1543-8.
Title: Lüke J, et al. The effect of adjuvant dimethylenastron, a mitotic Kinesin Eg5 inhibitor, in experimental glaucoma filtration surgery. Curr Eye Res. 2010 Dec;35(12):1090-8.
